Monte Rosa Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $113k | 20k | 5.65 |
| 2023-09-30 | $313k | 65k | 4.79 |
| 2023-06-30 | $368k | 54k | 6.85 |
| 2023-03-31 | $262k | 34k | 7.79 |
| 2022-12-31 | $212k | 28k | 7.61 |
| 2022-09-30 | $186k | 22k | 8.38 |
| 2022-06-30 | $99k | 10k | 9.78 |